 |
市场调查报告书
商品编码
1427191
全球数位疫苗市场规模、份额、成长分析、类型、部署模式、最终用户 - 产业预测，2023-2030 年Global Digital Vaccine Market Size, Share, Growth Analysis, By Type, By Deployment mode, By End user - Industry Forecast 2023-2030 |
||||||
2022年全球数位疫苗市场规模为16.976亿美元，从2023年的18.7858亿美元增长到2031年的42.2427亿美元，预计在预测期内（2024-2031年）将以复合年增长率增长。10.66%。
数位疫苗旨在透过虚拟实境、智慧型手机应用程式和人工智慧等创新数位技术，采用神经认知训练和助推策略来改变行为并改善身心健康。这些先进的工具旨在训练您的大脑并培养积极的习惯，提供价格实惠、易于使用的解决方案，适应广泛的需求，让您能够接触到广泛的人群并发挥作用。我们提供有针对性的支持。透过整合神经认知训练和助推策略，数位疫苗具有灌输更健康行为和丰富生活的巨大潜力。医疗保健 IT 的进步以及物联网、穿戴式科技、元宇宙平台和扩增实境概念的兴起正在改变数位疫苗格局。这些创新将促进对各种疾病和恐惧症进行更频繁的干预，美国国防部开发的虚拟创伤后压力症候群体验等措施就是例证。此外，人工智慧和机器学习越来越多地整合到数位疫苗管理系统中，以提高无针疫苗治疗多种病理的准确性和有效性。此外，人工智慧和机器学习在旨在促进年轻人健康生活方式的视讯游戏和行动应用程式的开发中也发挥关键作用。这种开创性的数位疫苗已获得美国专利，基于人工智慧驱动的化身。
自上而下和自下而上的方法已用于估计和检验全球数位疫苗市场的规模，并估计其他各个相关子市场的规模。用于估计市场规模的调查方法包括以下详细资讯：用于确定市场主要企业的二次研究，用于确定每个地区的市场占有率的主要和二次研究。整个过程包括研究主要企业的年度和财务报告以及广泛的采访，以获得执行长、副总裁、董事和行销负责人等行业领导者的重要见解。所有股份比率和细分均使用二手资讯确定并使用主要资讯检验。本研究涵盖的所有可能影响市场的参数都经过详细考虑，并透过初步研究检验并进行分析，以获得最终的定量和定性资料。
数位疫苗全球细分市场分析
全球数位疫苗市场根据类型、部署模式、最终用户和地区进行细分。按类型划分，市场分为疫苗管理软体、疫苗接种追踪应用程式和数位平台。依部署模式，市场分为云端基础的和本地的。按最终用户划分，市场分为医疗保健提供者、製药和生物技术公司、政府和上市公司、研究机构和学术中心以及患者和看护者。依地区划分，分为北美、欧洲、亚太地区、中东/非洲、拉丁美洲。
数位疫苗的全球市场驱动因素
世界各地的政府和医疗机构越来越重视疫苗接种工作，将其视为对抗传染病传播的关键策略。这种日益增加的关注产生了对能够简化和优化免疫工作的技术疫苗解决方案的巨大需求。世界卫生组织（WHO）的全球疫苗行动计画透过努力提高疫苗接种覆盖率和促进公平的疫苗取得来强调这一需求。透过利用行动应用程式等数位资源来安排预约和发送提醒，医疗保健提供者可以有效地与目标受众建立联繫并提高疫苗接种率。
全球数位疫苗市场的限制因素
管理数位疫苗系统中的敏感健康资料引起了对资料隐私和安全的担忧，并强调了保护个人健康资讯和维护免疫记录机密性的重要性。我强调这一点。如果没有有效的安全措施，资料外洩和未授权存取的可能性就会增加。解决这些问题并实施严格的资料保护通讯协定对于获得公众信任和普及数位疫苗解决方案的采用至关重要。
全球数位疫苗市场趋势
在疫苗供应链中利用区块链技术提供了去中心化、防篡改的帐本系统，大大提高了安全性和透明度。透过区块链，相关人员可以确保疫苗的真实性和可追溯性，减少替代品的威胁，并确保供应链每个阶段的适当储存和处理。 IBM 的「疫苗区块链」倡议就体现了这一点，利用区块链来监控疫苗从生产到管理的整个过程，提供清晰且审核的疫苗轨迹。
目录
- 执行摘要
- 调查方法
- 母市场分析
- 主要市场考察
- 技术分析
- 价格分析
- 供应链分析
- 价值链分析
- 市场生态系统
- 智慧财产权分析
- 贸易分析
- Start-Ups分析
- 原料分析
- 创新矩阵
- 研发线产品分析
- 总体经济指标
- 主要投资分析
- 关键成功因素
- 竞争程度
- 市场动态及展望
- 市场动态
- 促进因素
- 机会
- 抑制因素
- 任务
- 监管形势
- 波特的分析
- 对未来中断的特殊考虑
- 市场动态
- 全球数位疫苗市场：按类型
- 市场概况
- 疫苗管理软体
- 疫苗接种追踪应用
- 和数位平台
- 全球数位疫苗市场：依部署模式
- 市场概况
- 云端基础和本地
- 全球数位疫苗市场：按最终用户划分
- 市场概况
- 医护人员
- 製药和生物技术公司
- 政府和公共卫生机构
- 研究机构和学术中心
- 以及患者和看护者。
- 全球数位疫苗市场规模：按地区划分
- 市场概况
- 北美洲
- 美国
- 加拿大
- 欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲国家地区
- 亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
- 拉丁美洲
- 巴西
- 其他拉丁美洲地区
- 中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区
- 竞争形势
- 前5名企业对比
- 主要企业市场定位（2021年）
- 主要市场参与者所采取的策略
- 关键成功策略
- 近期市集活动
- 主要企业市场占有率（2021年）
- 主要企业简介
- Pfizer Inc.（US）
- Moderna, Inc.（US）
- Johnson & Johnson Services, Inc.（US）
- AstraZeneca PLC（UK）
- Novavax, Inc.（US）
- GlaxoSmithKline PLC（UK）
- Sanofi SA（France）
- Merck & Co., Inc.（US）
- BioNTech SE（Germany）
- Sinovac Biotech Ltd.（China）
- Bharat Biotech（India）
- Serum Institute of India Pvt. Ltd.（India）
- CanSino Biologics Inc.（China）
- Daiichi Sankyo Company, Limited（Japan）
- CureVac AG（Germany）
- Takeda Pharmaceutical Company Limited（Japan）
- Valneva SE（France）
- Janssen Pharmaceutica NV（Belgium）
- CSL Limited（Australia）
- Dynavax Technologies Corporation（US）
Global Digital Vaccine Market size was valued at USD 1697.60 million in 2022 and is poised to grow from USD 1878.58 million in 2023 to USD 4224.27 million by 2031, growing at a CAGR of 10.66% during the forecast period (2024-2031).
The aim of Digital Vaccines is to modify behaviors and improve mental and physical well-being by employing neurocognitive training and nudging tactics through innovative digital technologies like virtual reality, smartphone apps, and artificial intelligence. These advanced tools are designed to train the brain and foster positive habits, offering affordable, user-friendly solutions adaptable to diverse needs, thereby reaching a wide audience and providing targeted assistance. By integrating neurocognitive training and nudging strategies, digital vaccines hold great promise for instilling healthier behaviors and enriching lives. The landscape of digital vaccines has undergone a transformation propelled by advancements in healthcare IT and the rise of concepts like the Internet of Things, wearable technology, metaverse platforms, and augmented reality. These innovations facilitate more frequent interventions for various diseases and phobias, exemplified by initiatives like the Virtual PTSD Experience developed by the US Department of Defense. Moreover, artificial intelligence and machine learning are increasingly integrated into digital vaccine management systems to enhance the precision and efficacy of needle-free vaccines for treating diverse conditions. Additionally, AI and machine learning play a crucial role in the development of video games and mobile applications aimed at promoting healthy lifestyles among young individuals. The pioneering digital vaccine to receive a US patent relies on AI-driven avatars as its cornerstone.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Vaccine Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Digital Vaccine Market Segmental Analysis
Global Digital Vaccine Market is segmented on the basis of type, deployment mode, end user, and region. By type, the market is segmented into vaccine management software, vaccination tracking applications, and digital platforms. By deployment mode, the market is segmented into cloud-based and on-premise. By end user, the market is segmented into healthcare providers, pharmaceutical & biotechnology companies, government & public health agencies, research institutes & academic centers, and patients & caregivers. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Digital Vaccine Market
Governments and healthcare institutions globally are increasingly prioritizing immunization initiatives as a crucial strategy to combat the transmission of contagious illnesses. This intensified attention has spurred a significant need for technological vaccine solutions capable of streamlining and optimizing vaccination efforts. The World Health Organization's (WHO) Global Vaccine Action Plan underscores this imperative by striving to bolster vaccination rates and promote equitable vaccine accessibility. Leveraging digital resources like mobile applications for scheduling appointments and sending reminders can empower healthcare providers to efficiently connect with and mobilize target demographics, thereby bolstering vaccination coverage rates.
Restraints in the Global Digital Vaccine Market
The management of sensitive health data within digital vaccine systems prompts worries regarding data privacy and security, emphasizing the importance of safeguarding personal health information and upholding the confidentiality of vaccination records. Without effective security measures, the potential for data breaches and unauthorized access heightens. To instill public trust and promote the widespread acceptance of digital vaccine solutions, it is imperative to address these concerns and enforce rigorous data protection protocols.
Market Trends of the Global Digital Vaccine Market
Utilizing blockchain technology in vaccine supply chains provides a decentralized and tamper-proof ledger system, significantly improving security and transparency. Through blockchain, stakeholders can guarantee the authenticity and traceability of vaccines, mitigating the threat of counterfeit goods and ensuring appropriate storage and handling at every stage of the supply chain. IBM's "Blockchain for Vaccines" initiative exemplifies this, employing blockchain to monitor vaccines from production to administration, furnishing a clear and auditable account of the vaccine's trajectory.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Market Dynamics
- Global Digital Vaccine Market by Type
- Market Overview
- Vaccine management software
- vaccination tracking applications
- and digital platforms
- Global Digital Vaccine Market by Deployment mode
- Market Overview
- Cloud-based and on-premise
- Global Digital Vaccine Market by End user
- Market Overview
- Healthcare providers
- pharmaceutical & biotechnology companies
- government & public health agencies
- research institutes & academic centers
- and patients & caregivers
- Global Digital Vaccine Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Moderna, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson Services, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AstraZeneca PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novavax, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GlaxoSmithKline PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck & Co., Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioNTech SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sinovac Biotech Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bharat Biotech (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Serum Institute of India Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CanSino Biologics Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Daiichi Sankyo Company, Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CureVac AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Valneva SE (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Janssen Pharmaceutica NV (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CSL Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dynavax Technologies Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pfizer Inc. (US)
全球营养补充和疫苗市场规模、份额、成长分析（按类型、最终用户）- 产业预测，2024-2031 年
全球重组疫苗市场规模、份额、成长分析，按最终用户（儿童和成人）、配销通路（医院和疫苗接种中心）- 2024-2031 年行业预测
疫苗市场评估：按类型、给药途径、适应症、年龄层、最终用户和地区划分的机会和预测（2017-2031）
裂谷热疫苗市场，按产品类型、按应用、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测
全球疫苗市场：2024年
疾病控制和预防疫苗市场，按产品类型、给药途径、适应症、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测
全球疫苗技术市场
感染疾病疫苗市场：副产品、感染疾病和最终用户 - 全球预测 2024-2030
破伤风类毒素疫苗市场：按疫苗类型、年龄和最终用户划分 - 全球预测 2024-2030
反刍动物疫苗市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按动物类型、疫苗类型、疫苗适应症、给药途径、地区和竞争细分